AVADEL PHARMA Stock Price (NASDAQ:AVDL)

Add to My Stocks
$10.31 $0.4 (4.04%) AVDL stock closing price Jan 20, 2017 (Closing)
YOUR DAILY UPDATE ON
AVDL
AVADEL PHARMA
21 JAN 2017
amigobulls logo
AVDL hand_up
AVDL vs S&P 500
Closing Price: Jan 20, 2017
AVDL
$10.31 ( 4.04%)
S&P 500
2271.3 ( 0.34%)
AVDL
52 Week Price Range
1 Year Return: -0.96%
Q3 Growth*
Poor
Profitable ?
Yes
net image
2016 Q3 Net Profit
18.2%
PE Valuation
Expensive*
home image
Rating
AVDL AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

AVADEL PHARMA Snapshot Video

2 5 2

AVDL Stock Details

Prev Close* : $9.91
Market Cap:
$408.7M
Day Low: $9.93
52 Week Low: $7.56
Open: $9.93
Volume: 86854
Day High: $10.58
52 Week High: $15.45
Dividend:
N/A

Latest Stock Market News

Latest Articles

AVADEL PHARMA News - From Partners

AVDL Stockcharts

View AVDL PE ratio, PS ratio stocks charts and compare with peers.
AVDL Chart
Note: Compare AVADEL PHARMA stock price history with the index and industry peers.

AVADEL PHARMA Valuation

PE ratio
(price earnings ratio)
17.78
PS ratio (
price to sales ratio
)
2.82
PB ratio (
price to book ratio
)
9.4

AVADEL PHARMA Returns

ROE
(return on equity)
61%

AVADEL PHARMA Financial Ratios

Asset Turnover
0.52
Receivables Turnover
20.31
Debt to Equity
0.03

AVDL Industry Peers

Company Price Change (%)
Biocardia Inc (BCDA)0.890.07 (8.54%)
Karyopharm Therapeutics (KPTI)10.390.08 (0.76%)
Minerva Neurosciences (NERV)10.60.1 (0.95%)
La Jolla Pharma (LJPC)20.130.2 (1%)
Merck (MRK)62.532.2 (3.65%)
Acura Pharma (ACUR)0.60.03 (5.26%)
Depomed (DEPO)17.790.26 (1.44%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aralez Pharma (ARLZ)4.40.34 (8.37%)
Concert Pharma (CNCE)9.370.52 (5.88%)
AVADEL PHARMA (AVDL)10.310.4 (4.04%)
Nutraceutical International (NUTR)34.80.4 (1.16%)
Aratana Therapeutics (PETX)7.620.08 (1.06%)
La Jolla Pharma (LJPC)20.130.2 (1%)
Zoetis (ZTS)53.970.47 (0.88%)
Top gainers from Medical-Drugs industry
* As of Jan 21, 2017
CompanyPriceChange (%)
Synergy Pharma (SGYP)5.910.5 (7.8%)
Achaogen (AKAO)17.551.29 (6.85%)
Cempra (CEMP)30.2 (6.25%)
Xencor (XNCR)21.741.01 (4.44%)
Endo International (ENDP)12.340.56 (4.34%)
Egalet (EGLT)5.020.22 (4.2%)
Durect (DRRX)1.180.05 (4.07%)
Top losers from Medical-Drugs industry
* As of Jan 21, 2017

AVADEL PHARMA Financial Statements

income statement20152014201320122011
Net Sales Or Revenues173.2M14.77M22.44M26.1M32.6M
Net Income40.65M-88.92M-42.92M-3.22M-8.77M
Total Operating Expense90.82M32.98M39.98M40.26M35.89M
view AVADEL PHARMA income statement
balance sheet20152014201320122011
Total Assets214.97M174.2M116.25M117.31M69.4M
Total Liabilities147.11M149.31M125.76M86.8M39.6M
Shareholders Equity67.86M24.89M-9.51M30.5M29.79M
view AVADEL PHARMA balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-4.81M--1.69M-8.69M-4.39M
Net Cash From (Used By) Operating Activities84.29M-10.61M-20.67M-23.13M-10.32M
Increase (Decrease) In Prop Plant And Equipment-1.62M-1.72M-0.02M-1M-1.71M
view AVADEL PHARMA cashflow statement

AVADEL PHARMA Stock Message Board